Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 486 of 1,261
  1. US 10350265

    Therapeutic applications of Smad7

    The Regents of the University of Colorado, a Body Corporate · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  2. US 10350228

    Treatment of sickle cell disease and inflammatory conditions

    Regents of the University of Minnesota · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  3. US 10351618

    UTI fusion proteins

    Takeda Pharmaceutical Company Limited · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  4. US 10351598

    Peptide with anti-obesity and anti-diabetic efficacy and use thereof

    CAREGEN CO., LTD. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  5. US 10350312

    Magnetic microstructures for magnetic resonance imaging

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  6. US 10350249

    Reduction of milk glycans and their degradation products in the neonate gut

    The Regents of the University of California · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  7. US 10350170

    Solid preparation

    Takeda Pharmaceutical Company Limited · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  8. US 10350163

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  9. US 10350193

    Super-oxide dismutase mimetics

    Galera Labs, LLC · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  10. US 10350183

    Intravenous baclofen formulations and treatment methods

    Regents of the University of Minnesota · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  11. US 10351878

    Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

    The Regents of the University of California · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  12. US 10351844

    Methods and compositions for treating leber congenital amaurosis

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  13. US 10351606

    Mutated Salmonella enterica

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  14. US 10350162

    Methods and compositions for oral administration of exenatide

    Oramed Ltd. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  15. US 10351597

    Peptide with anti-obesity and anti-diabetes activity and use thereof

    CAREGEN CO., LTD. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  16. US 10351589

    3.alpha.-ethynyl, 3.beta.-hydroxy-5.alpha.-pregnan-20-oxime for use in the treatment of CNS disorders

    Umecrine Cognition AB · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  17. US 10351547

    Somatostatin modulators and uses thereof

    CRINETICS PHARMACEUTICALS, INC. · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  18. US 10351580

    Acene-based transmitter molecules for photon upconversion

    The Regents of the University of California · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  19. US 10351532

    Small molecule inhibitors of lactate dehydrogenase and methods of use thereof

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  20. US 10351522

    Sulfonamide derivative and pharmaceutically acceptable acid addition salt thereof

    The Board of Regents of the University of Texas System · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  21. US 10350296

    Chewable gelatin formulations

    Aspire Pharmaceuticals · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  22. US 10350292

    Agonist antibodies that bind human CD137 and uses thereof

    Compass Therapeutics LLC · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  23. US 10350306

    Methods and compositions for treating genetically linked diseases of the eye

    The United States of America as Represented by the Secretary, Dept. of Health and Human Services · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted
  24. US 10350256

    Compositions for the treatment of dermatological conditions, disorders or diseases

    Veit Hoermann Gesellschaft Für Unternehmenskommunikation mbH · Granted Jul 16, 2019 · Expires Jul 11, 2039

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.